You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH):董事會通過關於蘭州血制永昌蘭生單採血漿有限責任公司改造項目
格隆匯 06-02 22:09

格隆匯6月2日丨天壇生物(600161.SH)公佈,公司董事會七屆二十四次會議召開,審議通過關於蘭州血制永昌蘭生單採血漿有限責任公司改造項目議案

同意公司所屬蘭州血制永昌蘭生單採血漿有限責任公司改造項目,在甘肅省金昌市永昌縣城關鎮南關收費站對已購置房產進行改造,以滿足單採血漿站的使用要求,總改造面積2242平方米,採漿設計能力40/年。

項目總投資1400萬元,其中工程費用543.49萬元,工程建設其他費用80.24萬元,項目預備費44.64萬元,鋪底流動資金為22.43萬元,利舊資產709.2萬元,項目資金由蘭州血制自籌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account